BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 38613345)

  • 41. A risk model based on 10 ferroptosis regulators and markers established by LASSO-regularized linear Cox regression has a good prognostic value for ovarian cancer patients.
    Xiong T; Wang Y; Zhu C
    Diagn Pathol; 2024 Jan; 19(1):4. PubMed ID: 38178187
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Development and visualization of a risk prediction model for metabolic syndrome: a longitudinal cohort study based on health check-up data in China.
    Liu W; Tang X; Cui T; Zhao H; Song G
    Front Nutr; 2023; 10():1286654. PubMed ID: 38075230
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Application of Artificial Intelligence for Preoperative Diagnostic and Prognostic Prediction in Epithelial Ovarian Cancer Based on Blood Biomarkers.
    Kawakami E; Tabata J; Yanaihara N; Ishikawa T; Koseki K; Iida Y; Saito M; Komazaki H; Shapiro JS; Goto C; Akiyama Y; Saito R; Saito M; Takano H; Yamada K; Okamoto A
    Clin Cancer Res; 2019 May; 25(10):3006-3015. PubMed ID: 30979733
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Construction and validation of molecular subtype and signature of immune cell-related telomeric genes and prediction of prognosis and immunotherapy efficacy in ovarian cancer patients.
    Ling L; Li B; Wu H; Zhang K; Li S; Ke B; Zhu Z; Liu T; Liu P; Zhang B
    J Gene Med; 2024 Jan; 26(1):e3606. PubMed ID: 38282157
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of novel potential homologous repair deficiency-associated genes in pancreatic adenocarcinoma via WGCNA coexpression network analysis and machine learning.
    Liu C; Fang J; Kang W; Yang Y; Yu C; Chen H; Zhang Y; Ouyang H
    Cell Cycle; 2023 Nov; 22(21-22):2392-2408. PubMed ID: 38124367
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A Novel Platinum Resistance-Related Immune Gene Signature for Overall Survival Prediction in Patients with Ovarian Cancer.
    Zhou C; Ma J; Luo W; Hu J; Chen J; Liang S; He S
    Biochem Genet; 2024 Feb; 62(1):112-124. PubMed ID: 37270714
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Assessing of programmed cell death gene signature for predicting ovarian cancer prognosis and treatment response.
    Lian X; Liu B; Wang C; Wang S; Zhuang Y; Li X
    Front Endocrinol (Lausanne); 2023; 14():1182776. PubMed ID: 37342266
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification of a Prognostic Signature for Ovarian Cancer Based on Ubiquitin-Related Genes Suggesting a Potential Role for FBXO9.
    Luo X; Wang Y; Zhang H; Chen G; Sheng J; Tian X; Xue R; Wang Y
    Biomolecules; 2023 Nov; 13(12):. PubMed ID: 38136595
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Exploring the immune escape mechanisms in gastric cancer patients based on the deep AI algorithms and single-cell sequencing analysis.
    Chen W; Liu X; Wang H; Dai J; Li C; Hao Y; Jiang D
    J Cell Mol Med; 2024 May; 28(10):e18379. PubMed ID: 38752750
    [TBL] [Abstract][Full Text] [Related]  

  • 50. High-risk ovarian cancer based on 126-gene expression signature is uniquely characterized by downregulation of antigen presentation pathway.
    Yoshihara K; Tsunoda T; Shigemizu D; Fujiwara H; Hatae M; Fujiwara H; Masuzaki H; Katabuchi H; Kawakami Y; Okamoto A; Nogawa T; Matsumura N; Udagawa Y; Saito T; Itamochi H; Takano M; Miyagi E; Sudo T; Ushijima K; Iwase H; Seki H; Terao Y; Enomoto T; Mikami M; Akazawa K; Tsuda H; Moriya T; Tajima A; Inoue I; Tanaka K;
    Clin Cancer Res; 2012 Mar; 18(5):1374-85. PubMed ID: 22241791
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Development and verification of a 7-lncRNA prognostic model based on tumor immunity for patients with ovarian cancer.
    Feng J; Yu Y; Yin W; Qian S
    J Ovarian Res; 2023 Feb; 16(1):31. PubMed ID: 36739404
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Construction of diagnostic and prognostic models based on gene signatures of nasopharyngeal carcinoma by machine learning methods.
    Wang Y; He Y; Duan X; Pang H; Zhou P
    Transl Cancer Res; 2023 May; 12(5):1254-1269. PubMed ID: 37304552
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prognosis prediction of extremity and trunk wall soft-tissue sarcomas treated with surgical resection with radiomic analysis based on random survival forest.
    Yang Y; Ma X; Wang Y; Ding X
    Updates Surg; 2022 Feb; 74(1):355-365. PubMed ID: 34003477
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Machine learning developed a fibroblast-related signature for predicting clinical outcome and drug sensitivity in ovarian cancer.
    Fu W; Feng Q; Tao R
    Medicine (Baltimore); 2024 Apr; 103(16):e37783. PubMed ID: 38640321
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Use of machine learning-based integration to develop an immune-related signature for improving prognosis in patients with gastric cancer.
    Ning J; Sun K; Fan X; Jia K; Meng L; Wang X; Li H; Ma R; Liu S; Li F; Wang X
    Sci Rep; 2023 Apr; 13(1):7019. PubMed ID: 37120631
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification of a cancer associated fibroblasts-related index to predict prognosis and immune landscape in ovarian cancer.
    Ye Y; Zhang S; Jiang Y; Huang Y; Wang G; Zhang M; Gui Z; Wu Y; Bian G; Li P; Zhang M
    Sci Rep; 2023 Dec; 13(1):21565. PubMed ID: 38057405
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Application of machine learning algorithm in predicting distant metastasis of T1 gastric cancer.
    Tian H; Liu Z; Liu J; Zong Z; Chen Y; Zhang Z; Li H
    Sci Rep; 2023 Apr; 13(1):5741. PubMed ID: 37029221
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A novel autophagy-related gene signature associated with prognosis and immune microenvironment in ovarian cancer.
    Yang J; Wang C; Zhang Y; Cheng S; Wu M; Gu S; Xu S; Wu Y; Wang Y
    J Ovarian Res; 2023 Apr; 16(1):86. PubMed ID: 37120633
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A machine learning-based survival prediction model of high grade glioma by integration of clinical and dose-volume histogram parameters.
    Chen H; Li C; Zheng L; Lu W; Li Y; Wei Q
    Cancer Med; 2021 Apr; 10(8):2774-2786. PubMed ID: 33760360
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prognostic and immunotherapeutic potential of regulatory T cell-associated signature in ovarian cancer.
    Liu Y; Shan F; Sun Y; Kai H; Cao Y; Huang M; Liu J; Zhang P; Zheng Y
    J Cell Mol Med; 2024 Apr; 28(8):e18248. PubMed ID: 38520220
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.